IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2017 Holdings

Filed 2017-05-15 | 17 holdings | $5.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$2.4M100,00041.7%
Aurinia Pharma(AUPH)Common05156V102$1.8M252,12932.1%
Adaptimmune(ADAPY)SPONDS ADR00653A107$1.4M250,00023.9%
Crispr(CRSP)NAMEN AKTH17182108$56.6K2,601,8141.0%
ParatekCommon699374302$25.1K1,301,4130.4%
SientraCommon82621J105$18.5K2,199,0120.3%
Cymabay(CBAYUSD)Common23257D103$6.9K1,600,0000.1%
CascadianCommon14740B606$3.8K925,0000.1%
Chiasma(CHMA)Common16706W102$3.5K2,080,5950.1%
ProteonCommon74371L109$3.4K2,017,8720.1%
Lombard MedicalCommonG55598109$2.7K3,473,4520.0%
Dermira(DERMEUR)Common24983L104$2.4K70,0000.0%
Immune DesignCommon45252L103$2.4K352,3000.0%
HistogenixCommon43358V109$1.5K888,8890.0%
Senseonics(SENS1GBP)Common81727U105$920516,8820.0%
InnocollSPONDS ADR45780Q103$586537,2350.0%
NovanCommon66988N106$33753,3670.0%